1009334-28-4 Usage
Uses
Used in Organic Synthesis:
4,5-Dibromonicotinic acid is used as a building block in organic synthesis for the preparation of various bioactive molecules and pharmaceutical drugs. Its unique structure and reactivity make it a valuable intermediate in the synthesis of a wide range of compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4,5-dibromonicotinic acid is used as a key component in the development of new drugs. Its halogenated aromatic structure allows for the creation of novel molecules with potential therapeutic properties.
Used in Agrochemical Development:
4,5-Dibromonicotinic acid also has potential applications in the agrochemical industry, where it can be used to develop new pesticides or herbicides with improved efficacy and selectivity.
Used in Material Science:
Due to its unique chemical properties, 4,5-dibromonicotinic acid can be utilized in the development of new materials with specific characteristics, such as improved stability or enhanced performance in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1009334-28-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,9,3,3 and 4 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1009334-28:
(9*1)+(8*0)+(7*0)+(6*9)+(5*3)+(4*3)+(3*4)+(2*2)+(1*8)=114
114 % 10 = 4
So 1009334-28-4 is a valid CAS Registry Number.
1009334-28-4Relevant articles and documents
ALDOSTERONE SYNTHASE INHIBITORS
-
Page/Page column 53, (2016/06/28)
The present invention relates to compounds of the formulas (IA) and (IB) and pharmaceutically acceptable salts thereof, wherein A and R1 - R6, are as defined herein. The invention also relates to pharmaceutical compositions comprisin
AZA-BENZOFURANYL COMPOUNDS AND METHODS OF USE
-
Page/Page column 93, (2008/06/13)
The invention relates to azabenzofuranyl compounds of Formula (I) with anti-cancer and/or anti-inflammatory activity and more specifically to azabenzofuranyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
